Immunotherapy: Cancer vaccine triggers antiviral-type defences.

• Autores: Jolanda de Vries, Carl G. Figdor
• Localización: Nature: International weekly journal of science, ISSN 0028-0836, Vol. 534, Nº 7607, 2016, págs. 329-330
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • An immunotherapy approach targets nanoparticles to dendritic cells of the immune system, leading to an antitumour immune response with antiviral-like features. Initial clinical tests of this approach show promise. See Letter p.396